← Insider buys

STLN

The Oncology Institute, Inc. · Healthcare

Insiders bought $78K of The Oncology Institute, Inc. in the last 12 months

1 insider bought on 1 day.

$78KBought, 12 mo
$1.9MSold, 12 mo
$686.9MMarket cap

STLN over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

STLN after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

2 insider filings since 2026, newest first

About The Oncology Institute, Inc.

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.